<DOC>
	<DOCNO>NCT00988481</DOCNO>
	<brief_summary>The goal study generate pilot data explore addition augmentation ( additional ) medication patient suffer bulimia nervosa respond complete symptom resolution course standard medication treatment .</brief_summary>
	<brief_title>Topiramate Augmentation Bulimia Nervosa Partial Responders</brief_title>
	<detailed_description>The aim study determine whether addition augmentation medication ( topiramate 200mg/d ) confer additional reduction symptomatology BN patient receive six week standard pharmacological treatment fluoxetine 60 mg/day equivalent partial response symptomatic remission .</detailed_description>
	<mesh_term>Bulimia</mesh_term>
	<mesh_term>Bulimia Nervosa</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>Male female subject meet Diagnostic Statistical Manual IV edition ( DSMIV ) diagnostic criterion bulimia nervosa ( BN ) . Subjects must age 18 60 year . Subjects must currently demonstrate partial response standard BN pharmacotherapy treatment . Women childbearing potential must practice accepted method birth control ( barrier method oral contraceptive ) negative pregnancy test baseline . Subjects must good general health history , laboratory assessment physical exam . Subject 's BMI must &gt; 20 &lt; 27 kg/m^2 . Subjects allergic topiramate . Subjects meet DSMIV criterion anorexia nervosa . Women pregnant nursing time study . Subjects experience clinically significant , unstable neurological , cardiac , hepatic renal disease narrow angle glaucoma . Subjects history nephrolithiasis . Subjects serum potassium &lt; 3.0 mmol/L Subjects start psychotherapy study . Subjects currently past history meeting DSMIV diagnostic criterion schizophrenia , schizoaffective disorder , bipolar disorder . Subjects receive antipsychotic agent , mood stabilizer , antianxiety agent nonantidepressant psychotropic agent currently . Subjects currently history within past year meeting DSMIV diagnostic criterion substance abuse . Subjects experience clinically significant suicidal ideation ( subject refer appropriate caregiver ) . Subjects participate investigational drug study past 30 day . Subjects receive prescription medication oral contraceptive interact study medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Bulimia Nervosa</keyword>
	<keyword>Topiramate</keyword>
	<keyword>Augmentation</keyword>
</DOC>